Home › NCT05709782
Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC
RecruitingPhase 2
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
INCLUSION CRITERIA: 1. Age ≥ 18 years old 2. Radiographically documented disease of the spine within 4 weeks of registration (candidates with or without epidural disease allowed) 3. Candidate for spine SRS/SBRT as determined by treating Radiation Oncologist or Multidisciplinary Spine Conference review 4. Maximum of 3 contiguous vertebral levels involved with metastasis in the spine to be irradiated allowed 5. Diagnosis of cancer documented 6. Motor strength ≥ 4 out of 5 in the extremity affected by the level of spinal disease planned for radiation 7. Karnofsky Performance score (KPS) ≥ 40 or ECOG score ≤ 3 EXCLUSION CRITERIA: 1. Patients with highly radiosensitive histologies likely to respond to conventional radiation therapy alone (ie lymphoma, multiple myeloma, etc) 2. Patients who are unable to undergo MRI of the spine with contrast 3. Patients who are pregnant
About the study
To learn whether giving spinal stereotactic radiosurgery (SRSS) that uses a more advanced imaging scan method called Magnetic Resonance imaging with a Linear Accelerator (MR-LINAC) during treatment will lead to improved responses to treatment and better quality of life. SRSS is radiation therapy given to the area around your spine.
What is being tested
- Spine Radiosurgery (procedure)
- Magnetic Resonance imaging (device)
- MR-LINAC (radiation)
Sponsor: M.D. Anderson Cancer Center · Participants: 40 · Started: May 9, 2023
Contact the study team
- Debra N. Yeboa, MD · Phone: (713) 563-2415
Official record on ClinicalTrials.gov — NCT05709782
Locations in the U.S.
| Texas | M D Anderson Cancer Center, Houston |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.